Karen L. Smith - Aug 18, 2023 Form 3 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Karen L. Smith
Stock symbol
AUPH
Transactions as of
Aug 18, 2023
Transactions value $
$0
Form type
3
Date filed
8/21/2023, 04:16 PM
Previous filing
Jun 14, 2023
Next filing
Jun 6, 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.